Results For "NSE-pharma-news"

1 News Found

Ajanta Pharma Q4 FY26 revenue surges 21% to Rs 1,422 Crore; PAT climbs 18%

News | May 06, 2026

Ajanta Pharma Q4 FY26 revenue surges 21% to Rs 1,422 Crore; PAT climbs 18%

FY26 revenue rises 17% to Rs 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter

Latest Stories

Samsung Bioepis’ Pembrolizumab biosimilar SB27 meets phase 1 PK endpoints

Ajanta Pharma Q4 FY26 revenue surges 21% to Rs 1,422 Crore; PAT climbs 18%

Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Agentic AI poised to reshape pharma operations beyond pilot-stage adoption: Duraisamy Rajan Palani, Founder & CEO, Archimedis Digital

Duraisamy Rajan Palani Founder and CEO, Archimedis Digital

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Patient-centric innovation driving fight against neglected diseases: Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Sanjay Sarin, Continental Lead Asia and South Asia Director, DNDi

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

Kavinder Beniwal Chief Operational Officer, Motorica India

Packaging